Annual Retained Earnings
-$513.01 M
-$111.57 M-27.79%
December 31, 2023
Summary
- As of February 26, 2025, TSHA annual retained earnings is -$513.01 million, with the most recent change of -$111.57 million (-27.79%) on December 31, 2023.
- During the last 3 years, TSHA annual retained earnings has fallen by -$451.88 million (-739.26%).
- TSHA annual retained earnings is now -45909.60% below its all-time high of -$1.11 million, reached on December 31, 2019.
Performance
TSHA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$583.52 M
-$25.52 M-4.57%
September 30, 2024
Summary
- As of February 26, 2025, TSHA quarterly retained earnings is -$583.52 million, with the most recent change of -$25.52 million (-4.57%) on September 30, 2024.
- Over the past year, TSHA quarterly retained earnings has stayed the same.
- TSHA quarterly retained earnings is now -2001.56% below its all-time high of -$27.77 million, reached on June 30, 2020.
Performance
TSHA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
TSHA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.8% | 0.0% |
| 3 y3 years | -739.3% | 0.0% |
| 5 y5 years | -10000.0% | 0.0% |
TSHA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -117.7% | at low | -147.6% | at low |
| 5 y | 5-year | <-9999.0% | at low | -2001.6% | at low |
| alltime | all time | <-9999.0% | at low | -2001.6% | at low |
Taysha Gene Therapies Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$583.52 M(+4.6%) |
| Jun 2024 | - | -$558.00 M(+3.9%) |
| Mar 2024 | - | -$537.07 M(+4.7%) |
| Dec 2023 | -$513.01 M(+27.8%) | -$513.01 M(-8.5%) |
| Sep 2023 | - | -$560.75 M(+26.4%) |
| Jun 2023 | - | -$443.66 M(+5.9%) |
| Mar 2023 | - | -$419.06 M(+4.4%) |
| Dec 2022 | -$401.44 M | -$401.44 M(+16.0%) |
| Sep 2022 | - | -$345.94 M(+8.2%) |
| Jun 2022 | - | -$319.63 M(+11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -$285.76 M(+21.3%) |
| Dec 2021 | -$235.65 M(+285.5%) | -$235.65 M(+27.2%) |
| Sep 2021 | - | -$185.26 M(+38.2%) |
| Jun 2021 | - | -$134.08 M(+43.9%) |
| Mar 2021 | - | -$93.15 M(+52.4%) |
| Dec 2020 | -$61.13 M(+5382.2%) | - |
| Dec 2020 | - | -$61.13 M(+42.8%) |
| Sep 2020 | - | -$42.81 M(+54.2%) |
| Jun 2020 | - | -$27.77 M |
| Dec 2019 | -$1.11 M | - |
FAQ
- What is Taysha Gene Therapies annual retained earnings?
- What is the all time high annual retained earnings for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual retained earnings year-on-year change?
- What is Taysha Gene Therapies quarterly retained earnings?
- What is the all time high quarterly retained earnings for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly retained earnings year-on-year change?
What is Taysha Gene Therapies annual retained earnings?
The current annual retained earnings of TSHA is -$513.01 M
What is the all time high annual retained earnings for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual retained earnings is -$1.11 M
What is Taysha Gene Therapies annual retained earnings year-on-year change?
Over the past year, TSHA annual retained earnings has changed by -$111.57 M (-27.79%)
What is Taysha Gene Therapies quarterly retained earnings?
The current quarterly retained earnings of TSHA is -$583.52 M
What is the all time high quarterly retained earnings for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly retained earnings is -$27.77 M
What is Taysha Gene Therapies quarterly retained earnings year-on-year change?
Over the past year, TSHA quarterly retained earnings has changed by $0.00 (0.00%)